Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4)
Dokumenttyp:
Zeitschriftenaufsatz
Autor(en):
Bieber, Thomas; Reich, Kristian; Paul, Carle; Tsunemi, Yuichiro; Augustin, Matthias; Lacour, Jean-Philippe; Ghislain, Pierre-Dominique; Dutronc, Yves; Liao, Ran; Yang, Fan E.; Brinker, Dennis; DeLozier, Amy M.; Meskimen, Eric; Janes, Jonathan M.; Eyerich, Kilian
Login
BibTeX